Related Experiment Video
Updated: Jul 10, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia
Murray Grossman1, David J Libon, Mark S Forman
1Department of Neurology, 2 Gibson, University of Pennsylvania School of Medicine, 3400 Spruce St, Philadelphia, PA 19104-4283, USA. mgrossma@mail.med.upenn.edu
Archives of Neurology
|November 14, 2007
Summary
Accurate diagnosis of frontotemporal dementia (FTD) subtypes, including tau-positive FTD, tau-negative FTD, and Alzheimer disease, can be achieved using clinical, neuropsychological, and imaging data. This approach improves diagnostic accuracy for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Neuropathology
- Clinical Neurology
Background:
- Clinical-pathologic studies are essential for understanding brain-behavior relationships in neurodegenerative diseases.
- Accurate diagnosis is critical for effective management and treatment of conditions like frontotemporal dementia (FTD).
Purpose of the Study:
- To identify distinguishing clinical, neuropsychological, and imaging features in patients with frontotemporal dementia (FTD).
- To differentiate between pathologically confirmed tau-positive FTD, tau-negative FTD, and frontal-variant Alzheimer disease (AD).
- To enhance antemortem diagnostic accuracy for FTD spectrum disorders.
Main Methods:
- Retrospective clinical-pathologic survey of 61 patients with a clinical diagnosis of FTD.
- Participants underwent neuropsychological evaluation and autopsy-confirmed disease diagnosis.
- High-resolution structural magnetic resonance imaging (MRI) and detailed neuropsychological performance data were analyzed.
Main Results:
- Tau-positive FTD showed visual-spatial difficulties, extrapyramidal signs, and frontal/parietal atrophy on MRI.
- Tau-negative FTD presented with social, language, and executive function deficits, with frontal/temporal atrophy and pathology.
- Frontal-variant AD exhibited impaired delayed recall, temporal/hippocampal atrophy, and medial temporal pathology.
- A discriminant function analysis achieved 87.5% accuracy in grouping patients based on clinical and neuropsychological features.
Conclusions:
- Integrated clinical, neuropsychological, and neuroimaging profiles are valuable for accurate antemortem diagnosis of FTD.
- These distinct profiles aid in differentiating FTD subtypes and frontal-variant AD, improving diagnostic precision.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.